Find trials
Consejos para buscar

A Study to Create a Patient Decision Aid for Familial Hypercholesterolemia to Promote Shared Decision Making Between Patients and Physicians

Overview

Información sobre este estudio

The purpose of this study is to assist patients and clinicians in discussing the potential benefits and side effects of treatment of familial hypercholesterolemia (FH) and to develop a decision aid for use in a clinical setting.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Focus Group Discussion;
    • Patients with FH
      • Adults >18 years
      • Available for 60-90 minutes
    • Physicians
      • Consultants in the Mayo Clinic Network
      • Regularly see patients in an outpatient setting
  • Observations of Clinical Encounters and Field Testing and Iterative Development;
    • Patients
      • Adults ≥18 years
      • Appointment for FH treatment follow up OR appointment for initial FH consultation
    • Clinicians
      • Clinicians who meet with patients for treatment of FH
    • FH Patient Family Members
      • Adults ≥ 18 years
  • Focus Group Discussion;
    • Patients
      • Adults ≥18 years
      • Previous diagnosis of FH
      • Not involved in developing PDA or field testing PDA
    • Physicians
      • Consultants in the Mayo Clinic Network
      • Regularly see patients in an outpatient setting
      • Not involved in the initial development process of the decision aid or field testing
  • Patient Advisory Group (PAG);
    • Patients
      • Age >18

Exclusion Criteria:

  • Focus Group Discussion;
    • Patients with FH
      • Major barriers to providing informed consent (i.e dementia, severe hearing, or visual impairment)
    • Physicians
      • None
  • Observations of Clinical Encounters and Field Testing and Iterative Development;
    • Patients
      • Major barriers to providing informed consent (i.e. dementia, severe hearing or visual impairment)
    • Clinicians
      • None
    • FH Patient Family Members
      • None
  • Focus Group Discussion;
    • Patients
      • Major barriers to providing informed consent (i.e dementia, severe hearing, or visual impairment)
      • Prior involvement in the decision aid during the study
    • Physicians
      • Prior involvement in the decision aid during the study
  • Patient Advisory Group (PAG)
    • Patients
      • Major barriers to providing informed consent (i.e dementia, severe hearing loss, or visual impairment)

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Iftikhar Kullo, M.D.

Cerrado para la inscripción

Contact information:

Scott Nigbur

(507) 284-5647

Nigbur.Scott@mayo.edu

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20306927

Mayo Clinic Footer